HCA Healthcare, Inc.
Here’s whether HCA Healthcare, Inc. (HCA) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Positives: RSI 35 — healthy momentum range; strong 1-year return of +11.9%. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-2.72% over 10 days); 3-month momentum negative (-11.6%); rising volume on a downtrend (distribution, 1.19x avg). Currently 31.3% off its 52-week high. Score: -3/7.
HCA is trading below its 200-day MA ($457.76) — a key warning sign the longer-term trend is under pressure. An RSI of 35.1 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +11.9% compares to +16.5% for SPY (trailed the market by 4.5%). The current 31.3% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.